Completed PHASE3 NCT00002615

Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

A RANDOMISED, CONTROLLED TRIAL OF PRE- AND POST-OPERATIVE CHEMOTHERAPY IN PATIENTS WITH OPERABLE GASTRIC CANCER

Sponsor: Medical Research Council

Interventions cisplatin conventional surgery epirubicin hydrochloride fluorouracil

Updated 5 times since 2017 Last updated: Dec 18, 2013 Started: Jun 30, 1994 Completion: Dec 31, 2003

Listed as NCT00002615, this PHASE3 trial focuses on Gastric Cancer and remains completed. Sponsored by Medical Research Council, it has been updated 5 times since 1994, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical Research Council

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Epsom, Surrey, United Kingdom